150 + patients
treated

TO LEARN MORE ABOUT FARAWAVE AF ABLATION

> WATCH VIDEO

FARAPULSE

PULSED FIELD ABLATION

FARAPULSE PFA is fundamentally different from thermal modalities such as radiofrequency and cryoablation.

Through the precise and momentary creation of a therapeutic electric field, FARAPULSE PFA treats uniquely-sensitive myocardium.  Collateral, non-target tissues are spared due to their higher threshold to PFA.

FARAPULSE UPDATES

Go
Go
Go
Go
Go
Go

PRODUCTS

FARAPULSE is advancing tissue-selective PFA therapy on catheter and surgical platforms for both endocardial and epicardial approaches.

ENDO

FARAWAVE is an over-the-wire catheter designed to create durable and circumferential PFA lesions from a femoral approach.  The variable morphology of FARAWAVE’s distal end is designed to treat a range of anatomies.

ENDO

FARAFLEX is a deflectable catheter designed to facilitate focal placement of PFA therapy and accommodate multiple strategies including linear ablation.

ENDO

FARAPOINT (in development) enables ultra-precise, focal delivery of FARAPULSE PFA on a familiar linear and deflectable catheter platform.

EPI

FARAONE is designed to create a circumferential lesion around the pulmonary veins and posterior left atrium.  The catheter is surgically placed for an epicardial approach that does not require cardiopulmonary bypass.

Purpose-built, high-precision waveform generator designed to deliver tailored PFA therapy through all FARAPULSE catheters.

PEOPLE

BOARD OF DIRECTORS

Mary Byron
Boston Scientific Ventures

James Eadie, MD
Santé Ventures

Andrew ElBardisi, MD
Deerfield Management

Robert Weisskoff, Ph.D.
F-Prime Capital

Allan Zingeler
President and CEO, FARAPULSE

NEWS/CONTACT

NEWS RELEASES

Read more

GENERAL INFORMATION

info@farapulse.com

PHONE

650.422.3633

OFFICE

3715 Haven Ave, Suite 110
Menlo Park, CA 94025

Farapulse